BMPs exert a negative growth eect on various types of cells. We have previously reported that BMP-2 inhibited the growth of HS-72 mouse hybridoma cells by inducing p21 CIP1/WAF1 expression. In the present study, we demonstrated that BMP-2 activated the mouse p21
Introduction
Bone morphogenetic proteins (BMPs), members of the transforming growth factor-b (TGF-b) family, are multifunctional cytokines, and regulate dierentiation, apoptosis, and cell growth of a variety of cell types (Hogan, 1996; Whitman, 1998) . Growth inhibitory eects of BMPs have been reported in multipotent neural progenitor cells (Gross et al., 1996) , tooth bud epithelial cells (Jernvall et al., 1998) , hematopoietic stem cells (Bhatia et al., 1999) , and certain types of Blineage cells (Ishisaki et al., 1999; Kawamura et al., 2000) .
Members of the TGF-b family, including BMPs, initiate their signals by assembling speci®c type I and type II receptors to form active receptor complexes, in which the type II receptors phosphorylate and activate the type I receptors (Massague and Chen, 2000) . Signals from the activated type I receptors on the plasma membrane are transmitted and regulated by Smad proteins (Attisano and Wrana, 2000; Massague and Chen, 2000; ten Dijke et al., 2000; Zhang and Derynck, 1999) . Three classes of Smads have been identi®ed; the receptor-regulated Smad (R-Smad), the common-partner Smad (Co-Smad), the inhibitory Smad (I-Smad). Activated type I receptors dierentially phosphorylate R-Smad at two serine residues of the SSXS motif in the C terminal region. BMP type I receptors [activin receptor-like kinase 2 (ALK2), BMP receptor type IA (BMPR-IA, ALK3), BMPR-IB (ALK6)] phosphorylate Smad1, Smad5, and Smad8, whereas those of TGF-b [TGF-b receptor type I (TbR-I, ALK5)] and activins [activin receptor type IB (ActR-IB, ALK4)] phosphorylate Smad2 and Smad3. Phosphorylated R-Smads form complexes with Co-Smad (Smad4), translocate into the nucleus, and, in concert with other DNA-binding proteins, regulate gene transcription. A growing number of factors are becoming known, which physically and functionally cooperate with Smads to regulate transcription (Attisano and Wrana, 2000; Massague and Chen, 2000; ten Dijke et al., 2000; Zhang and Derynck, 1999) .
R-Smad and Co-Smad each can bind to DNA using the N-terminal domain designated as the Mad homology 1 (MH1) and activate transcription by the C-terminal domain (MH2). Close analyses of the promoter regions of the TGF-b-inducible genes and PCR-based random oligonucleotide selection have identi®ed Smad binding elements (SBEs) (Dennler et al., 1998; Jonk et al., 1998; Zawel et al., 1998) . Smad3 and Smad4 are considered to similarly bind to SBEs without speci®city while the binding of Smad2 to SBEs is disturbed by the presence of an extra amino acid sequence in the MH1. Recently a GC-rich sequence speci®c for Smad1 binding has been identi®ed (Ishida et al., 2000; Kusanagi et al., 2000) . Inhibitory Smads (I-Smads), such as Smad6 and Smad7, inhibit the phosphorylation of R-Smads and complex formation of R-Smad and Co-Smad, and, in doing so, disrupt the intracellular signaling of the TGF-b family members. p21
is a cyclin-dependent kinase (CDK) inhibitor (Sherr and Roberts, 1999) , that physically interacts with the cyclin-CDK complexes to inhibit their activities. The expression of p21 CIP1/WAF1 is transcriptionally regulated by p53 (Dulic et al., 1994; El-Deiry et al., 1993) and its related gene products (Jost et al., 1997; Kaghad et al., 1997; Osada et al., 1998; Yang et al., 1998) as well as retinoic acid (Liu et al., 1996a) , vitamin D3 (Liu et al., 1996b) , serum stimulation (Macleod et al., 1995) , epidermal growth factor, interferon-g (Chin et al., 1996) and TGF-b (Datto et al., 1995a) . Studies have uncovered the presence of regulatory motifs within the promoter region of p21
. We previously demonstrated that BMP-2 inhibited cellular proliferation of mouse B-cell hybridoma cells (Ishisaki et al., 1999; Yamato et al., 2000) . BMP-2 increased the level of p21 CIP1/WAF1 and subsequently that of hypophosphorylated retinoblastoma protein (Rb), resulting in inhibition of the G1-to-S progression .
In the present study, we investigated the mechanism by which BMP-2 regulates p21 CIP1/WAF1 expression and found that BMP-2 induced p21 CIP1/WAF1 via a sequence of 29 base pairs (b) located in its promoter region. Furthermore, we found that an oligonucleotide containing the 29-b region was capable of binding to Smad4 and phosphorylated Smad1 in the nuclear extract of BMP-2-stimulated HS-72 cells. Our results suggested that BMP-2 induced expression of p21 CIP1/ WAF1 might involve binding of Smad4 and phosphorylated Smad1 to the 29-b region in HS-72 cells.
Results

Activation of p21
CIP/WAF1 promoter by BMP-2
A mouse p21 CIP1/WAF1 genomic fragment containing an upstream sequence of the coding region (SalI ± XhoI fragment, 3.6 kb) (Figure 1 ) was obtained from a mouse p21 promoter-CAT construct (H) (El-Deiry et al., 1995) , placed adjacent to a luciferase reporter gene of the pGL3 plasmid, and designated as SalI-Luc. The construct was then transfected into HS-72 mouse hybridoma cells, which were exposed to various concentrations of BMP-2 for 24 h, and assayed for luciferase activity. As shown in Figure 2 , BMP-2 increased the reporter gene activity in a dose-dependent manner, with a maximal increase of 3.6-fold seen at 100 ng/ml, showing that the p21 CIP1/WAF1 promoter is capable of being induced by BMP-2. 
Identification of a BMP-responsive region
To localize the mouse p21 CIP1/WAF1 promoter region responsive to BMP-2 induction, a series of deletion constructs were generated (Figure 1 ). HS-72 cells were transfected with these constructs and stimulated by BMP-2 (100 ng/ml). As shown in Figure 3a , at least one BMP-responsive region was located between nucleotides 71994 (MscI site) and 71822 (EcoRV site) relative to the TATA box. This region contained a sequence of 29 b, which is highly conserved between mice and humans ( Figure 1 ) (El-Deiry et al., 1995) . The 29-b segment consists of a core motif of the ETS family (5'-GGAA-3') (Karim et al., 1990 ) and a p53-binding region of 20 b [the p53-binding site 2 (p53-BS-2)] (El- Deiry et al., 1995) . In p53-BS-2, we found an SBE (5'-GTCTGGGC-3') (Zawel et al., 1998) and an SBE-like sequence, in which the second nucleotide was A instead of T (5'-GACTGGGC-3'). To test if the 29-b region is important for BMP-2-mediated transcriptional activation, we generated a luciferase construct containing the 29-b region-deleted PvuII ± XhoI fragment of the p21 CIP1/WAF1 promoter ( Figure 1 , D29-bLuc). As shown in Figure 3b , BMP-2 increased the wild-type promoter (Pvu II-Luc) by 1.9-fold and the 29-b region-deleted promoter (D29-b-Luc) by 1.2-fold, suggesting that the 29-b region is important for BMPmediated activation of the p21 CIP1/WAF1 promoter. To test if the 29-b region could confer the BMP-2-mediated transcriptional activation, a single copy and three copies of the 29-b fragment were cloned in front of a minimal promoter of the adenovirus major late promoter (MLP) fused to the luciferase gene to generate 29-b61-MLP-Luc and 29-bx3-MLP-Luc, respectively. In HS-72 cells, the 29-b region conferred constitutive activation of the minimal promoter ( Figure  3c ). Exposure to BMP-2 activated the 29-bx1-minimal promoter and the 29-bx3-minimal promoter by 2.3-fold and 3.4-fold, respectively, showing that the 29-b region was responsive to BMP-2.
Recently, the proximal region of the human p21 CIP1/WAF1 promoter, which contains ®ve copies of Spl-binding sites, has been shown to be important for transcriptional activation by TGF-b. To examine the eect of BMP-2 on the proximal promoter of mouse p21
, a deletion construct containing a promoter fragment between nucleotide 7266 and the transcribed region was generated and tested for induction by BMP-2. As shown in Figure 3D , the proximal mouse p21 CIP1/WAF1 promoter was not activated by BMP-2.
Effect of HPV 16-E6 on BMP-mediated activation of the 29-b region
HS-72 cells express wild-type p53 and the 29-b region contains p53-BS-2 ( Figure 1 ). These facts raised the possibility that BMP-2 might transactivate the 29-b-promoter by modulating p53 transcriptional activity. To test this, we examined if the E6 oncogene of human papilloma virus type-16 (HPV-16), which inactivates mouse p53 (Song et al., 1998) , could inhibit activation of the 29-bx3-promoter by BMP-2. As shown in Figure 4 , E6 expression plasmid decrease activation of the 29-bx3-promoter by mitomycin C, but had no eect on BMP-2-mediated activation of the promoter, suggesting that BMP-2-mediated transactivation of this region was independent of endogenous p53.
Effects of active BMP type I receptors and Smads on the 29-b-minimal promoter
Using 29-bx3-MLP-Luc, we analysed the BMP-signals mediating p21 CIP1/WAF1 induction in HS-72 cells. HS-72 cells were transfected with 29-bx3-MLP-Luc and the expression plasmids encoding constitutively active mutants of BMP type I receptors (caALK2, caALK3, caALK6). As shown in Figure 5a , caALK2, caALK3, and caALK6 increased the activity of the 29-bx3-minimal promoter by 1.8-fold, 2.3-fold, and 2.2-fold, respectively, demonstrating that active forms of all the BMP type I receptors examined here were able to increase the activity of a promoter containing the 29-b sequence. We previously reported that BMP-2-induction of p21 CIP1/WAF1 and growth arrest was abrogated by overexpression of I-Smads (Smad6, Smad7) in HS-72 cells (Ishisaki et al., 1999) . To test if these I-Smads could modulate BMP-2-induced activation of the 29-b sequence, HS-72 cells were transfected with 29-bx3-MLP-Luc, plus either the Smad6-or Smad7-expression plasmid, and then stimulated by BMP-2. In the CIP1/WAF1 promoter (3.6 kb)-luciferase gene construct (SalI-Luc), and pRL-CMV as an internal control, and then incubated for 24 h in the presence of increasing concentrations of BMP-2, before being assayed for ®re¯y-and renilla-luciferase activities. Luciferase values shown in the ®gure are normalized to the renilla-luciferase activity expressed from pRL-CMV. Bars represent standard deviations of a triplicated experiment absence of I-Smads, BMP-2 increased the reporter gene activity by 6.5-fold, whereas the expression of Smad6 and Smad7 decreased BMP-2-mediated activation of the 29-bx3-minimal promoter to 1.7-fold and 1.5-fold, respectively (Figure 5b ), which was in accordance with our previous observation (Ishisaki et al., 1999) .
Activated BMP type I receptors phosphorylate Smad1, which forms a hetero-oligomer with Smad4 and other nuclear factors and binds to DNA, where . HS-72 cells were transfected with either SalI-Luc or a reporter construct containing the proximal promoter of mouse p21 CIP1/WAF1 (7266-Luc) and stimulated by BMP-2 (100 ng/ml). Normalized luciferase activity is shown as the mean+s.d. of a triplicate experiment the complex then regulates gene transcription. We tested if Smad1 and Smad4 could activate the 29-b sequence by examining the eects of Smad1, Smad4, and caALK6 on the activity of the 29-bx3-minimal promoter in HS-72 cells. Transfection of the caALK6-, Smad1-, and Smad4-expression plasmids alone increased the promoter activity by 4.0-fold, 2.7-fold, and 2.4-fold, respectively (Figure 5c ). Cotransfection of all these plasmids augmented the promoter activity by 19.0-fold. These results suggested that Smad4 and phosphorylated Smad1 were able to transactivate a promoter containing the 29-b sequence.
BMP-responsive sequence in the 29-b region
The 29-b region contains an SBE (5'-GTCTGGGC-3') (Zawel et al., 1998) . To test if the sequence confers BMP-2-inducibility, HS-72 cells were transfected with the minimal promoter-luciferase plasmids containing 12 repeats of the sequence [(GTCTGGGC)12-Luc] and a negative control sequence [(GTCCCAAC)12-Luc], and then stimulated by BMP-2. As shown in Figure 6 , BMP-2 increased the promoter activity of (GTCTGGGC)12-Luc by 40-fold, but had no eect on that of the control construct, suggesting that the SBE of 5'-GTCTGGGC-3' in the 29-b region could be activated by BMP-2.
Binding of exogenous Smads expressed by COS-1 cells to the 29-b sequence
We tested to see if Smads could directly bind to the 29-b region by a DNA anity precipitation assay (Tada et al., 1999; Wotton et al., 1999) . COS-1 cells were transiently transfected with expression plasmids for Myc-tagged R-Smad and Myc-tagged Smad4 (Smad2 and Smad4; Smad3 and Smad4), along with or without those for constitutively active forms of type I receptors (caALK4, caALK5) (Figure 7b ). Total cell lysates were prepared from the transfected cells, and examined for levels of Smads by the direct immunoblot analysis with an anti-Myc antibody. Levels of Smad2 and Smad4 were comparable and that of Smad 3 were three-fold higher than those of other types of Smads. The lysates were precipitated with biotinylated 29-b oligonucleotides and streptavidin-agarose beads, and immunoblotted. As shown in Figure 7a (top), Smad3 was precipitated by the 29-b fragment, which was enhanced by coexpression of the constitutively active mutant of TbR-I (caALK5). Binding of Smad4 to the 29-b fragment was detected when the lysate contained both Smad3 and caALK5, and mutation of the fragment decreased levels of DNA-bound Smad3 and Smad4, suggesting that Smad4 binding to the fragment was dependent of the presence of activated Smad3. Smad2 and Smad4 activated by the constitutively active mutant of ActR-IB (caALK4) was also found to be associated with the 29-b fragment, though with lower eciency than activated Smad3 and Smad4 (Figure 7a , bottom). Since Smad2 has been reported to lack the SBE binding, the Smad2 binding to the fragment might be dependent on Smad4, which might obtain higher DNA binding anity after forming a complex with activated Smad2.
Binding endogenous Smad4 and Smad1 of HS-72 cells to the 29-b sequence
The 29-b fragment was responsive to BMP-2-mediated transactivation in HS-72 cells. To examine if Smad1 and Smad4 of BMP-2-stimulated HS-72 cells could bind to the 29-b region, we performed a DNA anity precipitation assay. We tested levels of Smad4 and phosphorylated Smad1 in nuclear extracts from untreated and BMP-2-treated HS-72 cells by immunoblotting (Figure 8b, lanes 1 and 2) . Unstimulated HS-72 cells contained low levels of phosphorylated Smad1, which increased by stimulation with BMP-2. On the other hand, Smad4 levels were similar among the nuclear extracts from the untreated and BMP-2 treated HS-72 cells. To con®rm compartmentalization of the nuclear and cytoplasmic proteins, we examined levels of Smad2/3 and Smad4 in cytoplasmic and nuclear extracts from unstimulated HS-72 cells by the immunoblot analysis. As shown in Figure 8a , Smad2/ 3 was present in the cytoplasmic extract, whereas Smad4 was mainly present in the nuclear fraction. Immunological staining of a Cytospin preparation of HS-72 cells con®rmed that Smad4 was located mostly 
Discussion
BMPs have been reported to exert a negative growth eect on various cell types including immature neural cells (Gross et al., 1996) , dental epithelial cells (Jernvall et al., 1998) , hematopoietic stem cells (Bhatia et al., 1999) , mouse hybridoma cells (Ishisaki et al., 1999) , and human myeloma cells (Kawamura et al., 2000) . We have previously explored the mechanism by which BMP-2 causes growth suppression using HS-72 mouse B-cells (Ishisaki et al., 1999; Yamato et al., 2000) . In HS-72 cells, BMP induces p21 CIP1/WAF1 expression and, thereby, inhibits Rb phosphorylation . Underphoshorylated Rb blocks the cell-cycle progression from the G1 to S phase, which can be reverted by ectopic expression of the E7 oncoprotein of HPV-16, an antagonist of Rb and p21 CIP1/WAF1 . In the present study, we investigated the eect of BMP-2 on the promoter of p21 CIP1/WAF1 in HS-72 cells and found that it activated the transcription of p21
. Analysis of the promoter region of p21 CIP1/ WAF1 revealed that the 29-b region, which is conserved between mice and humans, was responsive to BMP-2-activation. Furthermore, Smad1, Smad4, and the constitutively active mutants of BMP type I receptors each enhanced transcription of a minimal promoter containing the 29-b sequence, and co-expression of these three molecules cooperatively augmented the activity of the 29-b sequence-promoter. We have previously shown that overexpression of I-Smads (Smad6, Smad7) inhibited the phosphorylation of Smad1 and induction of p21 CIP1/WAF1 (Ishisaki et al., 1999) . In the present study, we demonstrated that ISmads blocked BMP-2-induced activation of the 29-b sequence, and that the oligonucleotide containing the 29-b sequence could bind to Smad4 and phosphorylated Smad1 in a nuclear extract from BMP-2-treated HS-72 cells. These results suggested that BMP-2 induced activation of the p21 CIP1/WAF1 promoter might involve phosphorylation of Smad1 and subsequent binding of Smad1 and Smad4 to the 29-b region.
TGF-b triggers interaction between Smads and Sp1, and induces expression of p21 CIP1/WAF1 via an Sp1 binding sequence located in the vicinity of the TATA box in human cultured cells (Datto et al., 1995b; Li et al., 1998; Moustakas and Kardassis, 1998; Pardali et al., 2000) . We also analysed if the proximal promoter region of the mouse p21 CIP1/WAF1 was responsive to BMP-2 stimulation in mouse B lineage cells. We found that BMP-2 did not activated the proximal promoter in HS-72 cells. The structure of the proximal region of the mouse gene was dierent from that of the human gene: the human promoter contains ®ve copies of Sp1 sites whereas the mouse promoter contains only two copies. The mouse promoter might lack the sequence required for binding of Sp1 complexed with Smad proteins. Physical interaction between Sp1 and Smad1 also remained to be determined.
The 29-b region, located far upstream of the TATA box, did not contain a Sp1 site. Instead, the region contains a core binding sequence for ETS family members (5'-GGAA-3') (Karim et al., 1990; Macleod et al., 1995) and a p53-binding sequence (El-Deiry et al., 1995) , in which an SBE (5'-GTCTGGGC-3') (Zawel et al., 1998) and an SBE-like sequence (5'-GACTGGGC-3') are found. Since HS-72 cells express wild-type p53 , we determined if BMP-induced activation of the 29-b region was mediated through activation of endogenous wild-type p53. Expression of HPV-16 E6, an antagonist of wildtype p53, did not inhibit BMP-2 mediated transactivation of the 29-b region, suggesting that BMP-2-induced transactivation of the gene did not require wild-type p53. BMP-2 activated the promoter containing multiple copies of the SBE, suggesting that the SBE might be involved in BMP-2-activation of the 29-b region. It would be interesting to know if ETS-family members physically and functionally interact with Smads.
In summary, we found that BMP-2 activated the transcription of p21 CIP1/WAF1 and also identi®ed a BMPresponsive sequence of 29 b in the promoter region of the gene. The 29-b sequence was associated with Smad4 and phosphorylated Smad1 in the nuclear extract from BMP-2-treated HS-72 cells. Our results suggested that 
Materials and methods
Cell culture
HS-72 mouse B-cell hybridoma cells were cultured in Iscove's modi®ed Dulbecco's medium (IMDM, Sigma) supplemented with 10% fetal calf serum (FCS), 100 mg/ml of streptomycin, and 100 U/ml of penicillin G (Nishihara et al., 1995) . COS-1 cells were purchased from American type Culture Collection (CRL-1650), and grown in Dulbecco's minimal essential medium (DMEM) containing 10% FCS and antibiotics. Recombinant human BMP-2 was generously provided by Yamanouchi Pharmaceutical Co. Ltd. (Tokyo, Japan).
Plasmid constructs
The mouse p21 CIP1/WAF1 promoter CAT reporter plasmid (H) (El-Deiry et al., 1995) was a gift from Dr T Tokino (Sapporo Medical School). The 3.6-kilobase pair genomic fragment of mouse p21 CIP1/WAF1 was excised from the CAT construct H by digestion with Sa1I and XhoI, and then cloned into the XhoI site of the pGL3-basic luciferase reporter vector (Promega, Madison, WI, USA) to create Sa1I-Luc. A series of deletion constructs were generated as follows; PvuII ± XhoI fragment (2.8 kb), Pm1I ± XhoI fragment (2.5 kb), MscI ± XhoI fragment (2.0 kb), EcoRV ± XhoI fragment (1.9 kb), and HincII ± XhoI fragment (0.9 kb) were cloned into pGL3-basic at SmaI and XhoI sites, and designated as PvuII-Luc, Pm1I-Luc, MscI-Luc, EcoRV-Luc, and HincII-Luc, respectively. The proximal promoter region from nt 7266 to the transcribed region was obtained by the polymerase chain reaction using Sa1I-Luc as a template and cloned into pBL3 at NheI and XhoI sites. pMLP-Luc containing a minimal promoter consisting of the TATA box and the initiator sequence of the adenovirus major late promoter was provided by Dr P ten Dijke (The Netherlands Cancer Institute) (Dennler et al., 1998) . The sequence of the oligonucleotides cloned are: 29-b, 5'-tcgagGAGGAGGAAGACTGGGCATGTCTGGGCAGc-3' and its complementary strand; (GTCCCAAC), 5'-tcgagTGTCCCAACAAATGTCCCAACTTTTGTCCCAACc-3' and its complementary strand; (GTCTGGGC), 5'-tcgagTGTCTGGGCAAATGTCTGGGCTTTTGTCTGGGCc-3' and its complementary strand.
D29-b-Luc was generated by deleting the 29-b region (5'-GAGGAGGAAGACTGGGCATGTCTGGGCAG-3') from PvuII-Luc by a Gene editor in vitro site-directed mutagenesis system (Promega, Madison, WI, USA) and an oligonucleotide (5'-CTGTCTAGGTCAGCTAAATCCCATATGATCT- CTAGACATCGGAGAGC-3'). Expression plasmids for FLAG-Smad1, FLAG-Smad2, Flag-Smad3, FLAG-Smad4, Myc-Smad2, Myc-Smad3, Myc-Smad4, caALK2 (ALK2QD), caAL3 (ALK3QD), caAL4 (ALK4TD), caAL5 (ALK5TD), and caAL6 (ALK6QD) have been described previously Nakao et al., 1997) . HPV-16 E6 DNA (a kind gift from Dr T Kanda, the National Institute for Infectious Diseases, Tokyo, Japan) was subcloned into pcDNA3 (Invitrogen).
Transfection and luciferase assay
HS-72 cells were transiently transfected with the indicated plasmids and the internal control pRL-CMV (Promega) using Eectene (Qiagen GmbH, Hilden, Germany). Twenty hours after transfection, the cells were exposed to BMP-2 for another 20 h, and assayed for luciferase activities using a Dual luciferase assay kit (Promega). For transient transfection of COS-1 cells, 60 ± 80% of the con¯uent cells in six-well plates were transfected using FuGene6 (Roche Diagnostics), following the manufacturer's instructions.
Immunoblotting
Cells were lysed in lysis buer [20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40] supplemented with protease inhibitors. The immunoblot analysis was performed as described previously . Anti-Smad2/3 (clone 18), anti-Smad4 (clone B-8), and anti-Myc monoclonal antibodies (clone 9E10) were purchased from Transduction Laboratories (Lexington, KY, USA), Santa Cruz Biotechnology (Santa Cruz, CA), and Roche Diagnostics, respectively. Anti-phospho-Smad1 (Ser463/465) rabbit serum was purchased from New England Biolabs, Inc. (Beverly, MA, USA).
Nuclear and cytoplasmic extracts
Nuclear and cytoplasmic extracts were isolated from cultured cells using NE-PER nuclear and cytoplasmic extraction reagents (Pierce Chemical Co., Rochford, IL, USA), according to the manufacturer's protocol.
DNA affinity precipitation
The DNA anity precipitation assay was performed as described previously (Tada et al., 1999) . Brie¯y, protein extracts were incubated at 48C with 30 pmol of biotinylated double stranded oligonucleotides and 12 mg of poly(dI-dC)-poly(dI-dC) for 1 h. Proteins associated with biotinylated DNA were precipitated at 48C with 25 ml of streptavidinagarose beads for 30 min, washed four times with lysis buer, and analysed by immunoblotting. The sequences of the oligonucleotides are: wild-type 29-b, 5'-tcgagGAGGAGGAAGACTGGGCATGTCTGGGCAGc-3' and its complementary strand; mutant 29-b, 5'-tcgagGAGGAGGAATACTGGGAATTTCTGGGAAGc-3' and its complementary strand. Changes in the mutant 29-b are underlined. The oligonucleotides were biotinylated at the 5' end of the upper strand. Total cell lysates were prepared from COS-1 cells transfected with Smad-and ALK-expression plasmids. Nuclear (N) and cytoplasmic extracts (C) were prepared from unstimulated HS-72 cells, and examined for levels of Smad2/3 and Smad4 by immunoblotting. (b) DNA anity precipitation using nuclear extracts from HS-72 cells. Nuclear extracts were made from unstimulated (7) and BMP-2-stimulated HS-72 cells (+) (100 ng/ml, 3 h). They were incubated with biotinylated wild-type (w) and mutant (m) 29-b oligonucleotides, precipitated by streptavidin-beads, and then immunoblotted with anti-Smad4 monoclonal antibody (top) and anti-phospho-Smad1 rabbit serum (bottom). Levels of Smad4 and phosphorylated Smad1 in the nuclear extract were also examined by direct immunoblotting (lanes 1,2) 
